Advanced search
Publication Cover
Expert Review of Proteomics Volume 10, 2013 - Issue 6
Submit an article Journal homepage
213
Views
8
CrossRef citations to date
0
Altmetric
Reviews

Targeted quantitation of CVD-linked plasma proteins for biomarker verification and validation

Andrew J PercyUniversity of Victoria - Genome British Columbia Proteomics Centre, Vancouver Island Technology Park, #3101 - 4464 Markham St., Victoria, BC V8Z 7X8, Canada
,
Simon ByrnsUniversity of Alberta Hospital, 8440 - 112 Street, Edmonton, AB T6G 2B7, Canada
,
Andrew G ChambersUniversity of Victoria - Genome British Columbia Proteomics Centre, Vancouver Island Technology Park, #3101 - 4464 Markham St., Victoria, BC V8Z 7X8, Canada
&
Christoph H BorchersUniversity of Victoria - Genome British Columbia Proteomics Centre, Vancouver Island Technology Park, #3101 - 4464 Markham St., Victoria, BC V8Z 7X8, Canada;Department of Biochemistry and Microbiology, University of Victoria, Petch Building Room 207, 3800 Finnerty Rd., Victoria, BC V8P 5C2, CanadaCorrespondence[email protected]
Pages 567-578 | Published online: 09 Jan 2014

References

  • Genest J, McPherson R, Frohlich J et al. Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can. J. Cardiol. 25(10), 567–579 (2009).
  • Go AS, Mozaffarian D, Roger VL et al. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation 127(1), e6–e245 (2013).
  • Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 97(18), 1837–1847 (1998).
  • Wang TJ. Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction. Circulation 123(5), 551–565 (2011).
  • Hlatky MA, Greenland P, Arnett DK et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 119(17), 2408–2416 (2009).
  • Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation 118(22), 2243–2251, 2244p following 2251 (2008).
  • Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 297(6), 611–619 (2007).
  • Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol.Ther. 69(3), 89–95 (2001).
  • Hobbs FD. Cardiovascular disease: different strategies for primary and secondary prevention? Heart 90(10), 1217–1223 (2004).
  • Alvarez-Sabin J, Quintana M, Hernandez-Presa MA, Alvarez C, Chaves J, Ribo M. Therapeutic interventions and success in risk factor control for secondary prevention of stroke. J. Stroke Cerebrovasc. Dis. 18(6), 460–465 (2009).
  • Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll. Cardiol. 15(4), 827–832 (1990).
  • Folsom AR, Kronmal RA, Detrano RC et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch. Intern. Med. 168(12), 1333–1339 (2008).
  • Sharma K, Blaha MJ, Blumenthal RS, Musunuru K. Clinical and research applications of carotid intima-media thickness. Am. J. Cardiol. 103(9), 1316–1320 (2009).
  • Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell Proteomics 1(11), 845–867 (2002).
  • Tirumalai RS, Chan KC, Prieto DA, Issaq HJ, Conrads TP, Veenstra TD. Characterization of the low molecular weight human serum proteome. Mol. Cell Proteomics 2, 1096–1103 (2003).
  • Vassiliadis E, Barascuk N, Didangelos A, Karsdal MA. Novel cardiac-specific biomarkers and the cardiovascular continuum. Biomark. Insights 7, 45–57 (2012).
  • Thygesen K, Alpert JS, White HD et al. Universal definition of myocardial infarction. Circulation 116(22), 2634–2653 (2007).
  • Hall C. Essential biochemistry and physiology of (NT-pro)BNP. Eur. J. Heart Fail. 6(3), 257–260 (2004).
  • Motiwala SR, Januzzi JL. The role of natriuretic peptides as biomarkers for guiding the management of chronic heart failure. Clin. Pharmacol. Ther. 93(1), 57–67 (2013).
  • Maisel AS, Krishnaswamy P, Nowak RM et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N. Engl. J. Med. 347(3), 161–167 (2002).
  • Dunlay SM, Gerber Y, Weston SA, Killian JM, Redfield MM, Roger VL. Prognostic value of biomarkers in heart failure: application of novel methods in the community. Circ. Heart Fail. 2(5), 393–400 (2009).
  • Pedrotty DM, Morley MP, Cappola TP. Transcriptomic biomarkers of cardiovascular disease. Prog. Cardiovasc. Dis. 55(1), 64–69 (2012).
  • Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol. 24(8), 971–983 (2006).
  • Choudhary C, Mann M. Decoding signalling networks by mass spectrometry-based proteomics. Nat. Rev. Mol. Cell Biol. 11(6), 427–439 (2010).
  • Anderson L. Candidate-based proteomics in the search for biomarkers of cardiovascular disease. J. Physiol. 563, 23–60 (2005).
  • Aebersold R, Burlingame AL, Bradshaw RA. Western blots versus selected reaction monitoring assays: time to turn the tables? Mol. Cell Proteomics 12(9), 2381–2382 (2013).
  • Gillette MA, Carr SA. Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry. Nat. Methods 10, 28–34 (2013).
  • Marx V. Targeted proteomics. Nat. Methods 10(1), 19–22 (2013).
  • Carr SA, Anderson L. Protein quantitation through targeted mass spectrometry: the way out of biomarker purgatory? Clin. Chem. 54(11), 1749–1752 (2008).
  • Surinova S, Schiess R, Hüttenhain R, Cerciello F, Wollscheid B, Aebersold R. On the development of plasma protein biomarkers. J. Proteome Res. 10(1), 5–16 (2011).
  • Anderson NL. The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum. Clin. Chem. 56(2), 177–185 (2010).
  • Whiteaker JR, Lin C, Kennedy J et al. A targeted proteomics-based pipeline for verification of biomarkers in plasma. Nature Biotechnol. 29(7), 625–634 (2011).
  • Hoofnagle AN, Becker JO, Oda MN, Cavigiolio G, Mayer P, Vaisar T. Multiple-reaction monitoring-mass spectrometric assays can accurately measure the relative protein abundance in complex mixtures. Clin. Chem. 58(4), 777–778 (2012).
  • Percy AJ, Chambers AG, Parker CE, Borchers CH. Absolute quantitation of proteins in human blood by multiplexed multiple reaction monitoring mass spectrometry. Methods Mol. Biol. 1000, 167–189 (2013).
  • Picotti P, Aebersold R. Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat. Methods 9(6), 555–566 (2012).
  • Chace DH, Kalas TA. A biochemical perspective on the use of tandem mass spectrometry for newborn screening and clinical testing. Clin. Biochem. 38(4), 296–309 (2005).
  • Want EJ, Cravatt BF, Siuzdak G. The expanding role of mass spectrometry in metabolite profiling and characterization. Chembiochem 6, 1941–1951 (2005).
  • Percy AJ, Chambers AG, Yang J, Hardie D, Borchers CH. Advances in multiplexed MRM-based protein biomarker quantitation toward clinical utility. Biochim. Biophys. Acta doi:10.1016/j.bbapap.2013.06.008 (2013) ( Epub ahead of print).
  • Craig R, Cortens JP, Beavis RC. An open source system for analyzing, validating and storing protein identification data. J. Proteome Res. 3, 1234–1242 (2004).
  • Desiere F, Deutsch EW, Nesvizhskii AI et al. Integration with the human genome of peptide sequences obtained by high-throughput mass spectrometry. Genome Biol. 6(1), R9 (2005).
  • Farrah T, Deutsch EW, Kreisberg R et al. PASSEL: the PeptideAtlas SRMexperiment library. Proteomics 12(8), 1170–1175 (2012).
  • Kiyonami R, Schoen A, Prakash A et al. Increased selectivity, analytical precision, and throughput in targeted proteomics. Mol. Cell Proteomics 10(2), M110.002931 (2011).
  • Huttenhain R, Malmstrom J, Picotti P, Aebersold R. Perspectives of targeted mass spectrometry for protein biomarker verification. Curr. Opin. Chem. Biol. 13(5–6), 518–525 (2009).
  • Whiteaker JR, Paulovich AG. Peptide immunoaffinity enrichment coupled with mass spectrometry for peptide and protein quantification. Clin. Lab. Med. 31(3), 385–396 (2011).
  • Lemoine J, Fortin T, Salvador A, Jaffuel A, Charrier JP, Choquet-Kastylevsky G. The current status of clinical proteomics and the use of MRM and MRM(3) for biomarker validation. Expert Rev. Mol. Diagn. 12(4), 333–342 (2012).
  • Keshishian H, Addona T, Burgess M et al. Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution. Mol. Cell Proteomics 8, 2339–2349 (2009).
  • Brun V, Dupuis A, Adrait A et al. Isotope-labeled protein standards: toward absolute quantitative proteomics. Mol. Cell Proteomics 6(12), 2139–2149 (2007).
  • Brun V, Masselon C, Garin J, Dupuis A. Isotope dilution strategies for absolute quantitative proteomics. J. Proteomics 72, 740–749 (2009).
  • Huillet C, Adrait A, Lebert D et al. Accurate quantification of cardiovascular biomarkers in serum using Protein Standard Absolute Quantification (PSAQ™) and selected reaction monitoring. Mol. Cell Proteomics 11(2), M111.008235 (2012).
  • Kuhn E, Addona T, Keshishian H et al. Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry. Clin. Chem. 55(6), 1108–1117 (2009).
  • Anderson NL, Anderson NG, Haines LR, Hardie DB, Olafson RW, Pearson TW. Mass spectrometric quantitation of peptides and proteins using stable isotope standards and capture by anti-peptide antibodies (SISCAPA). J. Proteome Res. 3(2), 235–244 (2004).
  • Domanski D, Percy AJ, Yang J et al. MRM-based multiplexed quantitation of 67 putative cardiovascular disease biomarkers in human plasma. Proteomics 12(8), 1222–1243 (2012).
  • Anderson L, Hunter CL. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell Proteomics 5(4), 573–588 (2006).
  • Addona TA, Shi X, Keshishian H et al. A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease. Nat. Biotechnol. 29(7), 635–643 (2011).
  • Shi T, Fillmore TL, Sun X et al. Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum. Proc. Natl Acad. Sci. USA 109(38), 15395–15400 (2012).
  • Shi T, Sun X, Gao Y et al. Targeted Quantification of Low ng/mL Level Proteins in Human Serum without Immunoaffinity Depletion. J. Proteome Res. 12(7), 3353–3361 (2013).
  • Gilar M, Olivova P, Daly AE, Gebler JC. Two-dimensional separation of peptides using RP-RP-HPLC system with different pH in first and second separation dimensions. J. Sepn. Sci. 28(14), 1694–1703 (2005).
  • Wang Y, Yang F, Gritsenko MA et al. Reversed-phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells. Proteomics 11(10), 2019–2026 (2011).
  • Gilar M, Olivova P, Daly AE, Gebler JC. Orthogonality of separation in two-dimensional liquid chromatography. Anal. Chem. 77(19), 6426–6434 (2005).
  • Prensner JR, Rubin MA, Wei JT, Chinnaiyan AM. Beyond PSA: the next generation of prostate cancer biomarkers. Sci. Transl. Med. 4(127), 127rv123 (2012).
  • Liu T, Hossain M, Schepmoes AA et al. Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests. J. Proteomics 75(15), 4747–4757 (2012).
  • Razavi M, Frick LE, LaMarr WA et al. High-throughput SISCAPA quantitation of peptides from human plasma digests by ultrafast, liquid chromatography-free mass spectrometry. J. Proteome Res. 11(12), 5642–5649 (2012).
  • Jiang J, Parker CE, Hoadley KA, Perou CM, Boysen G, Borchers CH. Development of an immuno tandem mass spectrometry (iMALDI) assay for EGFR diagnosis. Proteomics Clin. Appl. 1, 1651–1659 (2007).
  • Jiang J, Parker CE, Fuller JR, Kawula TH, Borchers CH. An immunoaffinity tandem mass spectrometry (iMALDI) assay for detection of francisella tularensis. Anal. Chim. Acta 605, 70–79 (2007).
  • Reid JD, Holmes DT, Mason DR, Shah B, Borchers CH. Towards the development of an immuno MALDI (iMALDI) mass spectrometry assay for the diagnosis of hypertension. J. Am. Soc. Mass Spectrom. 21(10), 1680–1686 (2010).
  • Mason DR, Reid JD, Camenzind AG, Holmes DT, Borchers CH. Duplexed iMALDI for the detection of angiotensin I and angiotensin II. Methods 56(2), 213–222 (2012).
  • Adrait A, Lebert D, Trauchessec M et al. Development of a protein standard absolute quantification (PSAQ™) assay for the quantification of Staphylococcus aureus enterotoxin A in serum. J. Proteomics 75(10), 3041–3049 (2012).
  • Aguilar-Mahecha A, Kuzyk MA, Domanski D, Borchers CH, Basik M. Comparison of blood collection tubes and processing protocols for plasma proteomics studies. PLoS ONE 7(6), e38290 (2012).
  • Percy AJ, Chambers AG, Smith DS, Borchers CH. Standardized protocols for quality control of MRM-based plasma proteomic workflow. J. Proteome Res. 12(1), 222–233 (2013).
  • Addona TA, Abbatiello SE, Schilling B et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat. Biotechnol. 27(7), 633–641 (2009).
  • Abbatiello SE, Mani DR, Schilling B et al. Design, implementation, and multi-site evaluation of a system suitability protocol for the quantitative assessment of instrument performance in LC-MRM-MS. Mol. Cell Proteomics 12(9), 2623–2639 (2013).
  • Boja ES, Rodriguez H. The path to clinical proteomics research: integration of proteomics, genomics, clinical laboratory and regulatory science. Korean J. Lab. Med. 31(2), 61–71 (2011).
  • Li J, Kelm KB, Tezak Z. Regulatory perspective on translating proteomic biomarkers to clinical diagnostics. J. Proteomics 74(12), 2682–2690 (2011).
  • Regnier FE, Skates SJ, Mesri M et al. Protein-based multiplex assays: mock presubmissions to the US Food and Drug Administration. Clin. Chem. 56(2), 165–171 (2010).
  • Dietzen DJ, Rinaldo P, Whitley RJ et al. National academy of clinical biochemistry laboratory medicine practice guidelines: follow-up testing for metabolic disease identified by expanded newborn screening using tandem mass spectrometry; executive summary. Clin. Chem. 55(9), 1615–1626 (2009).
  • Wang CI, Zhang W, Song F, Liu Z, Liu S. A simple method for the analysis by MS/MS of underivatized amino acids on dry blood spots from newborn screening. Amino Acids 42(5), 1889–1895 (2012).
  • Percy AJ, Parker CE, Borchers CH. Pre-analytical and Analytical Variability in Absolute Quantitative MRM-B ased Plasma Proteomic Studies. Bioanalysis (2013) ( In Press).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.